Allkem Shareholders vote in favour of merger with Livent - Seite 4

This release was authorised by the Board of Directors of Allkem Limited.

Allkem Limited ABN 31 112 589 910 Level 35, 71 Eagle St Brisbane, QLD 4000	Investor Relations & Media Enquiries Andrew Barber M: [phone] E: [e-mail] Phoebe Lee P: [phone] E: [e-mail]		Connect [e-mail] [phone] www.allkem.co
		LinkedIn, Facebook, X, YouTube

IMPORTANT NOTICES

Not for release or distribution in the United States

This announcement has been prepared for publication in Australia and may not be released to U.S. wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction, and neither this announcement or anything attached to this announcement shall form the basis of any contract or commitment. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States except in transactions registered under the U.S. Securities Act of 1933 or exempt from, or not subject to, the registration of the U.S. Securities Act of 1933 and applicable U.S. state securities laws.

Annexure A: Voting results of the Scheme Meeting

The following information is provided in accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth):

A table accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed174d49-e63c-4875 ...

__________________________

¹ The Scheme remains subject to certain conditions. The Second Court Hearing will only occur if all of the remaining conditions precedent to the Scheme (other than in relation to the Court’s approval of the Scheme) have been satisfied or waived as at 8.00 am (Australian Western Standard Time) on 20 December 2023 (being the date that is currently scheduled to be the Second Court Date). Full details of the conditions precedent to the Scheme (and other terms) are set out in the Transaction Agreement entered into between Allkem, Livent and Arcadium Lithium (as amended from time to time), a summary of which is included in the Scheme Booklet and which is available on the ASX website at www.asx.com.au and on Allkem's website at https://www.allkem.co/.